VAC VERAFLO CLEANSE CHOICE: payments to doctors
Payments that named VAC VERAFLO CLEANSE CHOICE as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $250K
- Providers
- 963
- Transactions
- 1,196
- Average per transaction
- $209
The per-transaction average — $209 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 963 providers the average total is $260, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| KCI USA, Inc | $175,352 | 70.1% |
| KCI USA, Inc. | $74,859 | 29.9% |